Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants

Background and Objectives: Warfarin and a skeletal muscle relaxant are co-treatments in nearly a quarter-million annual United States (US) office visits. Despite international calls to minimize patient harm arising from anticoagulant drug interactions, scant data exist on clinical outcomes in real-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonard, Charles E., Brensinger, Colleen M., Bilker, Warren B., Soprano, Samantha E., Dhopeshwarkar, Neil, Hecht, Todd E. H., Kasner, Scott E., Nutescu, Edith A., Holbrook, Anne, Carr, Matthew, Ashcroft, Darren M., Chen, Cheng, Hennessy, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501796/
https://www.ncbi.nlm.nih.gov/pubmed/36143848
http://dx.doi.org/10.3390/medicina58091171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501796/
https://www.ncbi.nlm.nih.gov/pubmed/36143848
http://dx.doi.org/10.3390/medicina58091171

Ejemplares similares